Kymera Therapeutics
KYMR
KYMR
172 hedge funds and large institutions have $2B invested in Kymera Therapeutics in 2025 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 64 increasing their positions, 57 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
4% less funds holding
Funds holding: 180 → 172 (-8)
27% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 30
31% less capital invested
Capital invested by funds: $2.89B → $2B (-$890M)
Holders
172
Holding in Top 10
9
Calls
$7.84M
Puts
$6.59M
Top Buyers
| 1 | +$35.9M | |
| 2 | +$18.9M | |
| 3 | +$13.5M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$11.6M |
| 5 |
Millennium Management
New York
|
+$10.8M |
Top Sellers
| 1 | -$20.1M | |
| 2 | -$15.4M | |
| 3 | -$14.1M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$11.5M |
| 5 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$6.56M |